• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

骨髓来源的硫酸乙酰肝素增强骨形态发生蛋白-2(BMP-2)的成骨活性。

Bone marrow-derived heparan sulfate potentiates the osteogenic activity of bone morphogenetic protein-2 (BMP-2).

机构信息

Stem Cells and Tissue Repair Group, Institute of Medical Biology, A*STAR, Biopolis, Singapore 138648, Singapore.

出版信息

Bone. 2012 Apr;50(4):954-64. doi: 10.1016/j.bone.2011.12.013. Epub 2011 Dec 28.

DOI:10.1016/j.bone.2011.12.013
PMID:22227436
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3589980/
Abstract

Lowering the efficacious dose of bone morphogenetic protein-2 (BMP-2) for the repair of critical-sized bone defects is highly desirable, as supra-physiological amounts of BMP-2 have an increased risk of side effects and a greater economic burden for the healthcare system. To address this need, we explored the use of heparan sulfate (HS), a structural analog of heparin, to enhance BMP-2 activity. We demonstrate that HS isolated from a bone marrow stromal cell line (HS-5) and heparin each enhances BMP-2-induced osteogenesis in C2C12 myoblasts through increased ALP activity and osteocalcin mRNA expression. Commercially available HS variants from porcine kidney and bovine lung do not generate effects as great as HS5. Heparin and HS5 influence BMP-2 activity by (i) prolonging BMP-2 half-life, (ii) reducing interactions between BMP-2 with its antagonist noggin, and (iii) modulating BMP2 distribution on the cell surface. Importantly, long-term supplementation of HS5 but not heparin greatly enhances BMP-2-induced bone formation in vitro and in vivo. These results show that bone marrow-derived HS effectively supports bone formation, and suggest its applicability in bone repair by selectively facilitating the delivery and bioavailability of BMP-2.

摘要

降低骨形态发生蛋白-2(BMP-2)的有效剂量对于修复临界尺寸的骨缺损非常重要,因为超生理剂量的 BMP-2 会增加副作用的风险,并给医疗保健系统带来更大的经济负担。为了满足这一需求,我们探索了使用硫酸乙酰肝素(HS),即肝素的结构类似物,来增强 BMP-2 的活性。我们证明,从骨髓基质细胞系(HS-5)中分离出的 HS 和肝素都能通过增加碱性磷酸酶(ALP)活性和骨钙素 mRNA 表达来增强 C2C12 成肌细胞中 BMP-2 诱导的成骨作用。来自猪肾和牛肺的商业 HS 变体没有像 HS5 那样产生巨大的效果。肝素和 HS5 通过以下方式影响 BMP-2 活性:(i)延长 BMP-2 的半衰期,(ii)减少 BMP-2 与其拮抗剂 noggin 之间的相互作用,以及(iii)调节 BMP2 在细胞表面的分布。重要的是,HS5 的长期补充而不是肝素的补充,极大地增强了 BMP-2 诱导的体外和体内骨形成。这些结果表明,骨髓来源的 HS 能有效地支持骨形成,并表明其通过选择性地促进 BMP-2 的递送和生物利用度,在骨修复中的适用性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2298/3589980/f74700a84f4f/nihms-442806-f0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2298/3589980/997aeef4c9a0/nihms-442806-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2298/3589980/926c059dca35/nihms-442806-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2298/3589980/825805497381/nihms-442806-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2298/3589980/1cd156f8f1e8/nihms-442806-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2298/3589980/5314295733bb/nihms-442806-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2298/3589980/0746e70bc21c/nihms-442806-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2298/3589980/f74700a84f4f/nihms-442806-f0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2298/3589980/997aeef4c9a0/nihms-442806-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2298/3589980/926c059dca35/nihms-442806-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2298/3589980/825805497381/nihms-442806-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2298/3589980/1cd156f8f1e8/nihms-442806-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2298/3589980/5314295733bb/nihms-442806-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2298/3589980/0746e70bc21c/nihms-442806-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2298/3589980/f74700a84f4f/nihms-442806-f0007.jpg

相似文献

1
Bone marrow-derived heparan sulfate potentiates the osteogenic activity of bone morphogenetic protein-2 (BMP-2).骨髓来源的硫酸乙酰肝素增强骨形态发生蛋白-2(BMP-2)的成骨活性。
Bone. 2012 Apr;50(4):954-64. doi: 10.1016/j.bone.2011.12.013. Epub 2011 Dec 28.
2
Bone morphogenetic protein receptor in the osteogenic differentiation of rat bone marrow stromal cells.骨形态发生蛋白受体在大鼠骨髓基质细胞成骨分化中的作用。
Yonsei Med J. 2010 Sep;51(5):740-5. doi: 10.3349/ymj.2010.51.5.740.
3
Affinity-selected heparan sulfate for bone repair.亲和选择的硫酸乙酰肝素在骨修复中的应用。
Biomaterials. 2013 Jul;34(22):5594-605. doi: 10.1016/j.biomaterials.2013.04.017. Epub 2013 Apr 28.
4
Design of hydrogels to stabilize and enhance bone morphogenetic protein activity by heparin mimetics.通过肝素类似物设计水凝胶以稳定和增强骨形态发生蛋白活性。
Acta Biomater. 2018 May;72:45-54. doi: 10.1016/j.actbio.2018.03.034. Epub 2018 Mar 26.
5
Dexamethasone enhances osteogenic differentiation of bone marrow- and muscle-derived stromal cells and augments ectopic bone formation induced by bone morphogenetic protein-2.地塞米松可增强骨髓和肌肉来源的基质细胞的成骨分化,并增强骨形态发生蛋白-2诱导的异位骨形成。
PLoS One. 2015 Feb 6;10(2):e0116462. doi: 10.1371/journal.pone.0116462. eCollection 2015.
6
Bone morphogenetic protein-2 decorated silk fibroin films induce osteogenic differentiation of human bone marrow stromal cells.骨形态发生蛋白-2修饰的丝素蛋白膜诱导人骨髓基质细胞的成骨分化。
J Biomed Mater Res A. 2004 Dec 1;71(3):528-37. doi: 10.1002/jbm.a.30186.
7
RNA interference for noggin enhances the biological activity of bone morphogenetic proteins in vivo and in vitro.针对头蛋白的RNA干扰增强了骨形态发生蛋白在体内和体外的生物活性。
J Bone Miner Metab. 2009;27(4):402-11. doi: 10.1007/s00774-009-0054-x. Epub 2009 Feb 28.
8
Regulation of BMP-induced transcription in cultured human bone marrow stromal cells.培养的人骨髓基质细胞中骨形态发生蛋白诱导转录的调控
J Bone Joint Surg Am. 2003;85-A Suppl 3:19-28. doi: 10.2106/00004623-200300003-00005.
9
Enhanced bioactivity of bone morphogenetic protein-2 with low dose of 2-N, 6-O-sulfated chitosan in vitro and in vivo.低剂量2-N,6-O-硫酸化壳聚糖增强骨形态发生蛋白-2在体内外的生物活性。
Biomaterials. 2009 Mar;30(9):1715-24. doi: 10.1016/j.biomaterials.2008.12.016. Epub 2009 Jan 7.
10
Human adipose-derived stromal cells respond to and elaborate bone morphogenetic protein-2 during in vitro osteogenic differentiation.人脂肪来源的基质细胞在体外成骨分化过程中对骨形态发生蛋白-2 作出反应并进行阐述。
Plast Reconstr Surg. 2010 Feb;125(2):483-493. doi: 10.1097/PRS.0b013e3181c82d75.

引用本文的文献

1
LAPONITE® nano-silicates potentiate the angiogenic effects of FG-4592 and osteogenic effects of BMP-2.拉蓬特®纳米硅酸盐增强了 FG-4592 的血管生成作用和 BMP-2 的成骨作用。
Biomater Sci. 2024 Oct 22;12(21):5610-5619. doi: 10.1039/d4bm00636d.
2
Control of tissue homeostasis by the extracellular matrix: Synthetic heparan sulfate as a promising therapeutic for periodontal health and bone regeneration.细胞外基质对组织稳态的调控:合成肝素硫酸作为牙周健康和骨再生有前景的治疗剂。
Periodontol 2000. 2024 Feb;94(1):510-531. doi: 10.1111/prd.12515. Epub 2023 Aug 24.
3
Growth factor and macromolecular crowding supplementation in human tenocyte culture.

本文引用的文献

1
The effect of human bone marrow stroma-derived heparan sulfate on the ex vivo expansion of human cord blood hematopoietic stem cells.人骨髓基质来源硫酸乙酰肝素对人脐血造血干细胞体外扩增的影响。
Pharm Res. 2011 Jun;28(6):1385-94. doi: 10.1007/s11095-010-0352-y. Epub 2010 Dec 24.
2
Heparan sulfate acts as a bone morphogenetic protein coreceptor by facilitating ligand-induced receptor hetero-oligomerization.硫酸乙酰肝素通过促进配体诱导的受体异型寡聚化而作为骨形态发生蛋白的核心受体。
Mol Biol Cell. 2010 Nov 15;21(22):4028-41. doi: 10.1091/mbc.E10-04-0348. Epub 2010 Sep 22.
3
Differences between in vitro viability and differentiation and in vivo bone-forming efficacy of human mesenchymal stem cells cultured on PCL-TCP scaffolds.
人肌腱细胞培养中的生长因子和大分子拥挤补充
Biomater Biosyst. 2021 Jan 30;1:100009. doi: 10.1016/j.bbiosy.2021.100009. eCollection 2021 Mar.
4
Regulation of stem cell fate by HSPGs: implication in hair follicle cycling.硫酸乙酰肝素蛋白聚糖对干细胞命运的调控:在毛囊周期中的意义。
NPJ Regen Med. 2022 Dec 28;7(1):77. doi: 10.1038/s41536-022-00267-y.
5
Recapitulation of growth factor-enriched microenvironment via BMP receptor activating hydrogel.通过骨形态发生蛋白(BMP)受体激活水凝胶对富含生长因子的微环境进行重现。
Bioact Mater. 2022 Jul 5;20:638-650. doi: 10.1016/j.bioactmat.2022.06.012. eCollection 2023 Feb.
6
High Molecular Weight Poly(glutamic acid) to Improve BMP2-Induced Osteogenic Differentiation.高分子量聚谷氨酸促进 BMP2 诱导的成骨分化。
Mol Pharm. 2022 Dec 5;19(12):4565-4575. doi: 10.1021/acs.molpharmaceut.2c00141. Epub 2022 Jun 8.
7
The Auxiliary Role of Heparin in Bone Regeneration and its Application in Bone Substitute Materials.肝素在骨再生中的辅助作用及其在骨替代材料中的应用
Front Bioeng Biotechnol. 2022 May 12;10:837172. doi: 10.3389/fbioe.2022.837172. eCollection 2022.
8
Bone morphogenetic protein 2-induced cellular chemotaxis drives tissue patterning during critical-sized bone defect healing: an in silico study.骨形态发生蛋白 2 诱导的细胞趋化作用驱动临界尺寸骨缺损愈合过程中的组织形态发生:一项计算机研究。
Biomech Model Mechanobiol. 2021 Aug;20(4):1627-1644. doi: 10.1007/s10237-021-01466-0. Epub 2021 May 28.
9
Cyclodextrin-Based Supramolecular Complexes of Osteoinductive Agents for Dental Tissue Regeneration.用于牙组织再生的骨诱导剂的环糊精基超分子复合物
Pharmaceutics. 2021 Jan 21;13(2):136. doi: 10.3390/pharmaceutics13020136.
10
Heparan Sulfate Proteoglycans: Key Mediators of Stem Cell Function.硫酸乙酰肝素蛋白聚糖:干细胞功能的关键调节因子
Front Cell Dev Biol. 2020 Nov 19;8:581213. doi: 10.3389/fcell.2020.581213. eCollection 2020.
在 PCL-TCP 支架上培养的人骨髓间充质干细胞的体外活力和分化差异及其体内成骨效果。
Biomaterials. 2010 Nov;31(31):7960-70. doi: 10.1016/j.biomaterials.2010.07.001. Epub 2010 Aug 4.
4
Heparin-conjugated fibrin as an injectable system for sustained delivery of bone morphogenetic protein-2.肝素结合纤维蛋白作为一种可注射系统,用于持续递送骨形态发生蛋白-2。
Tissue Eng Part A. 2010 Apr;16(4):1225-33. doi: 10.1089/ten.TEA.2009.0390.
5
Purification and characterization of heparan sulfate from human primary osteoblasts.从人原代成骨细胞中纯化和表征硫酸乙酰肝素。
J Cell Biochem. 2009 Dec 1;108(5):1132-42. doi: 10.1002/jcb.22340.
6
Hematopoietic stem cells regulate mesenchymal stromal cell induction into osteoblasts thereby participating in the formation of the stem cell niche.造血干细胞调节间充质基质细胞向成骨细胞的诱导,从而参与干细胞微环境的形成。
Stem Cells. 2008 Aug;26(8):2042-51. doi: 10.1634/stemcells.2008-0149. Epub 2008 May 22.
7
Long-term delivery enhances in vivo osteogenic efficacy of bone morphogenetic protein-2 compared to short-term delivery.与短期递送相比,长期递送可增强骨形态发生蛋白-2的体内成骨效力。
Biochem Biophys Res Commun. 2008 May 2;369(2):774-80. doi: 10.1016/j.bbrc.2008.02.099. Epub 2008 Feb 29.
8
The effect of crosslinking heparin to demineralized bone matrix on mechanical strength and specific binding to human bone morphogenetic protein-2.将肝素交联至脱矿骨基质对机械强度及与人骨形态发生蛋白-2特异性结合的影响。
Biomaterials. 2008 Mar;29(9):1189-97. doi: 10.1016/j.biomaterials.2007.11.032.
9
Optimized bone regeneration based on sustained release from three-dimensional fibrous PLGA/HAp composite scaffolds loaded with BMP-2.基于负载骨形态发生蛋白-2的三维纤维聚乳酸-羟基乙酸共聚物/羟基磷灰石复合支架缓释实现的优化骨再生
Biotechnol Bioeng. 2008 Mar 1;99(4):996-1006. doi: 10.1002/bit.21648.
10
Clinical effectiveness and cost-effectiveness of bone morphogenetic proteins in the non-healing of fractures and spinal fusion: a systematic review.骨形态发生蛋白在骨折不愈合和脊柱融合中的临床疗效及成本效益:一项系统评价
Health Technol Assess. 2007 Aug;11(30):1-150, iii-iv. doi: 10.3310/hta11300.